Summary Ikonisys, Inc. (Ikonisys) is a medical device company that develops, manufactures and markets cell-based diagnostic products. The company offers products such as robotic microscope, and software applications such as oncoFISH bladder, oncoFISH her2, ikonisoft explorer, ikonisoft explorer tissue and IkoniWAN. It offers solutions to automated microscopy system, diagnostic applications, and CAP accredited laboratory. Ikonisys offers IkoniWAN that provide telepath logy gateway secures remote access to Ikonisoft viewer. The company's products are used in cancer detection and prenatal detection of genetic disorders and fertility. It markets products through a network of distributors to clinical laboratories. Ikonisys is headquartered in New Haven, Connecticut, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Ikonisys, Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Ikonisys, Inc. Company Snapshot 5 Ikonisys, Inc. Company Overview 5 Ikonisys, Inc. Pipeline Products and Clinical Trials Overview 6 Ikonisys, Inc. - Pipeline Analysis Overview 8 Key Facts 8 Ikonisys, Inc. - Major Products and Services 9 Ikonisys, Inc. Pipeline Products by Development Stage 10 Ikonisys, Inc. Pipeline Products Overview 11 oncoFISH breast 11 oncoFISH breast Product Overview 11 oncoFISH colorectal 12 oncoFISH colorectal Product Overview 12 oncoFISH ovarian 13 oncoFISH ovarian Product Overview 13 oncoFISH prostate 14 oncoFISH prostate Product Overview 14 Ikonisys, Inc. - Key Competitors 15 Ikonisys, Inc. - Key Employees 16 Ikonisys, Inc. - Locations And Subsidiaries 17 Head Office 17 Recent Developments 18 Ikonisys, Inc., Recent Developments 18 Feb 09, 2010: Ikonisys To Exhibit oncoFISH Cervical Test At The Eurogin 2010 Cervical Cancer Prevention Conference 18 Oct 28, 2008: Ikonisys Receives FDA Clearance For Non-Invasive, HER-2 Breast Cancer Test 18 Oct 14, 2008: Ikonisys Reports Positive Results From Clinical Study Designed To Evaluate The Efficacy Of Circulating Tumor Cell Detection With Ikonisys' Automated Microscope 18 Jun 18, 2008: Ikonisys Appoints CFO 19 Feb 01, 2008: Ikonisys Initiates Clinical Trial For Early, Non-Invasive Testing Of Down Syndrome 19 Appendix 20 Methodology 20 About GlobalData 20 Contact Us 20 Disclaimer 20
List of Tables
Ikonisys, Inc. Pipeline Products and Clinical Trials Overview 6 Ikonisys, Inc. Pipeline Products by Equipment Type 6 Ikonisys, Inc. Pipeline Products by Indication 7 Ikonisys, Inc., Key Facts 8 Ikonisys, Inc., Major Products and Services 9 Ikonisys, Inc. Number of Pipeline Products by Development Stage 10 Ikonisys, Inc. Pipeline Products Summary by Development Stage 10 oncoFISH breast - Product Status 11 oncoFISH breast - Product Description 11 oncoFISH colorectal - Product Status 12 oncoFISH colorectal - Product Description 12 oncoFISH ovarian - Product Status 13 oncoFISH ovarian - Product Description 13 oncoFISH prostate - Product Status 14 oncoFISH prostate - Product Description 14 Ikonisys, Inc., Key Employees 16
List of Figures
Ikonisys, Inc. Pipeline Products by Equipment Type 7 Ikonisys, Inc. Pipeline Products by Development Stage 10
Global activated carbon market size is likely to be valued at USD 5.3 billion by 2020; as per a new research report by Radiant Insights, Inc. Increase in commercial & residential waste water treatment demand owing to escalation in water prices is antRead More...
Global electric water heaters market is expected to be valued at USD 29,322.4 million by 2022, as per a new research report by Radiant Insights, Inc. Escalating demand across extensive range of domestic applications is expected to drive demand. EvolvRead More...
Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous industRead More...
Global automotive ECU market is projected to be valued at USD 45.98 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising use in infotainment systems coupled with high deployment in electric vehicles applications is expectedRead More...
Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanomRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.